From: The annual conference of National Cancer Institute - Cairo University "Bridging Gaps in Oncology"
Risk Factor | Mortality | p value |
---|---|---|
Septic shock | 55% | <0.001 |
Septic shock with MDRO | 72% | Â |
Cardiac impairment/inotropic support | 65.60% | Â |
Presence Of Central venous line | 18.30% | Â |
Episode duration >18 days | 20.50% | Â |
Start of antimicrobial in relation to start of chemotherapy < 16 days | 33% | Â |